Sinai BioDesign Hosts FDA Representative to Discuss Medical Device Submissions
Sinai BioDesign, an organization of the Icahn School of Medicine at Mount Sinai focused on the development of biomedical technologies, hosted U.S. Food and Drug Administration (FDA) representative Joshua Chetta on October 1 to discuss the regulations and requirements for device submission …
Moving Science into the Clinic
How Mount Sinai Drives Real-World Applications of Research Discoveries By Douglas McCormick From the fall issue of Mount Sinai Science & Medicine magazine The long-anticipated combination of artificial intelligence and molecular biology is now producing personalized, precision treatments for patients at Mount …
Life Science Academic Partnerships Part 1: an Ideal Marriage to Fuel Organic Growth
By Mark Ralph, Executive Director & Global Head, Contracts & Alliance Management, Boehringer Ingelheim Pharmaceuticals, Inc. In today’s innovation environment, external collaboration is one of the most powerful methods to discover and develop new treatments and research tools, particularly between industry and …
MSIP Recognizes Innovators at 2018 SINAInnovations Awards Ceremony
Mount Sinai Innovation Partners (MSIP) presented the Inventor of the Year award to Anne Schaefer, MD, PhD, and the Deal of the Year award to Julio A. Aguirre-Ghiso, PhD, at the 2018 SinaInnovations awards ceremony. The awards recognize exceptional Mount Sinai innovators …
The Pioneers of Kidney Disease Prevention: Meet Mount Sinai Nephrologists Steven Coca and Girish Nadkarni
As colleagues in Mount Sinai’s Division of Nephrology, Steven Coca, DO, MS and Girish Nadkarni, MD, MPH share a mutual passion for revolutionizing chronic kidney disease management on a global scale. Drs. Coca and Nadkarni are the co-inventors of KidneyTrackTM, an artificial …
Mount Sinai Health System Top 10 Researchers
It’s our pleasure to introduce the Top 10 Mount Sinai researchers who have shared their discoveries with MSIP in the form of a Technology Disclosure, a written description of the inventor(s) technology. Disclosures allow MSIP to survey the landscape of translational discoveries …
Mount Sinai and Stony Brook Announce Affiliation
August 11, 2016 – Stony Brook Medicine and the Mount Sinai Health System today announced that they are entering into an affiliation agreement that includes collaboration on research, academic programs and clinical care initiatives, effective immediately. The institutions launched the partnership to heighten …